TRIKAFTA gran 100mg/50mg/75mg + 75mg sach 56 pce
7680692120021
CH-69212
R07AX32
03.99.0.
Reimbursement limitations:
TRIKAFTA_gra
Après garantie de prise en charge des frais par l’assureur et après consultation préalable du …
1 / 3
google
Details
- Product number
- 6921201
- CPT
- -
- Packaging group
- 56
- Unit
- Sachet(s)
- Composition
- Granulat Morgendosis (elexacaftorum 100 mg / tezacaftorum 50 mg / ivacaftorum 75 mg): elexacaftorum 100 mg, tezacaftorum 50 mg, ivacaftorum 75 mg, hypromellosum, hypromellosi acetas succinas, natrii laurilsulfas, lactosum monohydricum 235.7 mg, mannitolum, carmellosum natricum conexum, sucralosum, magnesii stearas, silica colloidalis anhydrica, ad granulatum pro charta corresp. natrium max. 3.44 mg. Granulat Abenddosis (ivacaftorum 75 mg): ivacaftorum 75 mg, hypromellosi acetas succinas, natrii laurilsulfas, lactosum monohydricum 109.8 mg, mannitolum, carmellosum natricum conexum, sucralosum, magnesii stearas, silica colloidalis anhydrica, ad granulatum pro charta corresp. natrium max. 1.49 mg.
Articles (1)
Trikafta 100 mg / 50 mg / 75 mg, 75 mg, Granulat
Granulat
56
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
GRAN
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
GRAN
|
75.0 MG | Substance | Wirkstoff (Principe actif) |
|
GRAN
|
- | Substance | HNIDK |
|
GRAN
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
GRAN
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
GRAN
|
75.0 MG | Substance | Wirkstoff (Principe actif) |
|
GRAN
|
- | Substance | HNIDK |
|
GRAN
|
109.8 MG | Substance | HBESI |
|
GRAN
|
- | Substance | HNIDK |
|
GRAN
|
- | Substance | HNIDK |
|
GRAN
|
- | Substance | HNIDK |
|
GRAN
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
GRAN
|
- | Substance | HNIDK |
|
GRAN
|
235.7 MG | Substance | HBESI |
|
GRAN
|
- | Substance | HNIDK |
|
GRAN
|
- | Substance | HNIDK |
|
GRAN
|
- | Substance | HNIDK |
|
GRAN
|
- | Substance | HNIDK |
|
GRAN
|
- | Substance | HNIDK |
|
GRAN
|
- | Substance | HNIDK |
|
GRAN
|
- | Substance | HBESI |
|
GRAN
|
- | Substance | HNIDK |
|
GRAN
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 14565.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2025
Authorization holder
Vertex Pharmaceuticals (CH) GmbH
6300 Zug
Authorization information
- Swissmedic authorization number
- 69212
- Drug name
- Trikafta, Granulat
- Galenic form
- GRB
- ATC Code
- R07AX32
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/06/2024
- Authorization expiration date
- 12/06/2029
- IT number
- 03.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TRIKAFTA gran 100mg/50mg/75mg + 75mg sach 56 pce
- Description (DE)
- TRIKAFTA Gran 100mg/50mg/75mg + 75mg Btl 56 Stk
- Market launch
- 13/06/2024
- Narcotic (BTM)
- No